|
2005
Theinert SM, Pronest MM, Peris K, Sterry W, Walden P.
Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
Infect Immun. 2005 Oct;73(10):7018-21.
Theinert SM, Pronest MM, Peris K, Sterry W, Walden P.
Identification of the testis-specific protein 10 (TSGA10) as serologically defined tumour-associated antigen in primary cutaneous T-cell lymphoma.
Br J Dermatol. 2005 Sep;153(3):639-41.
Bredenbeck A, Losch FO, Sharav T, Eichler-Mertens M, Filter M, Givehchi A, Sterry W, Wrede P, Walden P.
Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy.
J Immunol. 2005 Jun 1;174(11):6716-24.
Demine R, Walden P.
Testing the role of gp96 as peptide chaperone in antigen processing.
J Biol Chem. 2005 May 6;280(18):17573-8.
Trefzer U, Herberth G, Wohlan K, Milling A, Thiemann M, Sharav T, Sparbier K, Sterry W, Walden P.
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results.
Vaccine. 2005 Mar 18;23(17-18):2367-73.
Thomas Linnemann, Sylke Gellrich, Ansgar Lukowsky, Arlett Mielke, Heike Audring, Wolfram Sterry and Peter Walden.
On the possible involvement of superantigens in the pathogenesis of cutaneous T cell lymphoma.
Br. J. Dermatol. 2005. 152: 827
|
